Hi Daniele I recently made a change in truncate (added cumulative distribution for twinned intensities), however I'm not sure whether 6.0.2 incorporates that change. I've not seen either of the problems you report before, all I can suggest is you re-compile truncate with the debug (-g switch), with no optimisation (no -O), and also bounds-checking turned on might be informative (-fbounds-check assuming you're using g77). Then run again with the debugger and post the traceback. It shouldn't need the ulimit command to work correctly since there are no huge arrays in truncate, and the "segmentation violation" error usually indicates array bounds overflow (which programmers in general are very lax at checking!).
Cheers -- Ian > -----Original Message----- > From: CCP4 bulletin board [mailto:[EMAIL PROTECTED] On > Behalf Of Daniele de Sanctis > Sent: 04 April 2007 10:39 > To: CCP4BB@JISCMAIL.AC.UK > Subject: [ccp4bb] truncate error on x86_64 > > Dear all, > > i installed ccp4 6.0.2 on an amd64 machine running Ubuntu 6.10, 64bit > version. Everything is running fine except a problem i have with > truncate. At the beginning it failed giving a "segmentation violation" > error which i overcame using "ulimit -s unlimited". Now I got another > error (quite general indeed) > > "The program run with command: truncate HKLIN > "/home/daddah/kpn8/b4x4/kpn8_3_001_scala1.mtz" HKLOUT > "/tmp/daddah/b4x4_15_1_mtz.tmp" PLOT /tmp/daddah/b4x4_15_falloff.plt > has failed with error message > Floating Exception" > > any idea? > > d > > > -- > Daniele de Sanctis, PhD > > Homo sum humani nil alienum a me puto > ______________________________________________________________ > phone ++ 351 21 4469 662 fax ++ 351 21 4433 664 > > e-mail [EMAIL PROTECTED], [EMAIL PROTECTED] > > Mailing address: > ITQB, Av. República, Apartato 127 > 2781-901 Oeiras > Portugal > > Disclaimer This communication is confidential and may contain privileged information intended solely for the named addressee(s). It may not be used or disclosed except for the purpose for which it has been sent. If you are not the intended recipient you must not review, use, disclose, copy, distribute or take any action in reliance upon it. If you have received this communication in error, please notify Astex Therapeutics Ltd by emailing [EMAIL PROTECTED] and destroy all copies of the message and any attached documents. Astex Therapeutics Ltd monitors, controls and protects all its messaging traffic in compliance with its corporate email policy. The Company accepts no liability or responsibility for any onward transmission or use of emails and attachments having left the Astex Therapeutics domain. Unless expressly stated, opinions in this message are those of the individual sender and not of Astex Therapeutics Ltd. The recipient should check this email and any attachments for the presence of computer viruses. Astex Therapeutics Ltd accepts no liability for damage caused by any virus transmitted by this email. E-mail is susceptible to data corruption, interception, unauthorized amendment, and tampering, Astex Therapeutics Ltd only send and receive e-mails on the basis that the Company is not liable for any such alteration or any consequences thereof. Astex Therapeutics Ltd., Registered in England at 436 Cambridge Science Park, Cambridge CB4 0QA under number 3751674
